Evolving Castration Resistance and Prostate Specific Membrane Antigen Expression: Implications for Patient Management

Evolving Castration Resistance and Prostate Specific Membrane Antigen Expression: Implications for Patient Management

Metastatic castration-resistant prostate cancer (mCRPC) remains an incurable disease, despite multiple novel treatment options. The role of prostate-specific membrane antigen (PSMA) in the process of mCRPC development has long been underestimated. During the last years, a new understanding of the un...

Full description

Bibliographic Details
Main Authors: Katharina Kessel, Christof Bernemann, Martin Bögemann, Kambiz Rahbar
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
prostate-specific membrane antigen
PSMA
metastatic castration-resistant prostate cancer
mCRPC
<sup>177</sup>Lu-PSMA-RLT
theranostics
Online Access:https://www.mdpi.com/2072-6694/13/14/3556

Similar Items

Similar Items